Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

CDK 4/6 inhibitorOngoingActive not recruitingPhase 3Open NCT03425838 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT03425838 · Trial Tracker · ComplyRx